Vaccinex, Inc. ( VCNX) - Key Metrics
VCNX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q4 | $0.10 | -$1.61 | -$1.87 | -$1.87 |
| 2024Q3 | $0.03 | -$2.83 | -$1.58 | -$1.59 |
| 2024Q2 | $0.13 | -$3.10 | -$2.43 | -$2.44 |
| 2024Q1 | $0.08 | -$2.94 | -$3.49 | -$3.49 |
| 2023Q4 | -$0.98 | -$8.44 | -$9.14 | -$9.14 |
VCNX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q4 | 0% | -0.15 |
| 2024Q3 | 0% | -0.30 |
| 2024Q2 | 0% | -0.53 |
| 2024Q1 | 0% | -0.59 |
| 2023Q4 | 0% | -0.27 |
VCNX
Price: $1.25
52 week price:
Earnings Per Share: -8.88 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 494085
Market Capitalization: 2.6 million